INO: Inovio Pharmaceuticals, Inc. Price to Earnings Ratio

Symbol and logo of brand Inovio Pharmaceuticals Inc (INO)

The price history of Inovio Pharmaceuticals (INO) on the GURU.Markets platform with the -2.20 indicator reflects the dynamics of a company that delegates primary testing and drug production to external partners while retaining exclusive patent rights. Inovio Pharmaceuticals develops advanced DNA therapy methods and creates innovative intradermal drug delivery systems. Management is currently shifting its strategic focus toward treating rare lung pathologies while navigating regulatory challenges.

inovio.com (INO) Price to Earnings Ratio: for the period 07/04/2022 - 11/14/2026

Analytical breakdowns for Inovio Pharmaceuticals

- share price and expert price forecast:
Price Performance Chart inovio.com|INO - Consensus Target
- market capitalization information:
Market Value Inovio Pharmaceuticals|INO - Enterprise Value
- book capitalization information:
Net Assets per Share Inovio|INO - Company Book Value|Market Value to Book Value inovio.com|INO - Cumulative Company Assets
- debt and solvency information:
Total Debt to Capital Inovio Pharmaceuticals|INO - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Inovio Pharma|INO - Company Aggregate Debts|Debts to Net Assets Inovio Pharmaceuticals|INO - Company Long-Term Debt|Company Short-Term Indebtedness Inovio|Immediate Liquidity inovio.com
- earnings and market multiples details:
INO - Net Income|Expected Profit Inovio Pharmaceuticals|INO - P/E Multiple|Market Cap to Projected Earnings Inovio Pharmaceuticals, Inc.|INO - Price/Earnings to Growth Ratio|Company Value to EBITDA Inovio Pharmaceuticals|INO - Operating profit before deduction of amortization|Earnings per share for the trailing year Inovio|INO - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months inovio.com|INO - Earnings growth in current year|Expected earnings per share trend next year Inovio Pharmaceuticals
- sales volume and revenue indicators:
INO - Revenue and Sales Volume|Projected Sales Volume inovio.com|INO - Price-to-Revenue Ratio|Forward Price to Sales Inovio Pharmaceuticals
Summary company analysis:Inovio Pharmaceuticals
Core merchandise of Inovio Pharmaceuticals

The P/E ratio determines the cost per unit of profit, allowing for an assessment of the premium paid for an asset relative to its income-generating capacity. The forward P/E dynamics of a company visualize market expectations for future business capitalization. Calculated levels are formed through the ratio of the market share price to net earnings per share. For Inovio Pharmaceuticals (INO), this indicator reflects the value of its proprietary DNA medicine platform and R&D expenditures.

Analysis of competing companies

GILD: Company Value to Net Income|Price to Earnings Ratio CDTX (Cidara Corp)|Price to Earnings Ratio NVAX (Novavax Inc)|P/E Multiple CVAC (CureVac Corp)|Business Payback Period Valneva Vaccines (VALN)|VIR - Price to Earnings Ratio|Company Value to Net Income SIGA (siga.com)|EBS (Emergent BioSolutions Inc.) - Price to Earnings Ratio|Atea Pharma (AVIR) - P/E Multiple|Price to Earnings Ratio Invivyd Inc|Enanta Pharmaceuticals, Inc (ENTA) - Business Payback Period|P/E Multiple HLVX|Business Payback Period kalaristx.com|Price to Earnings Ratio Dyadic International, Inc. DYAI|NNVC: Price to Earnings Multiple|TLPH - Price to Earnings Ratio|Market Cap to Earnings Cocrystal Pharma Corp|TRAW (trawspharma.com) - Price to Earnings Ratio|DWTX (Dogwood Therapeutics) - Price to Earnings Ratio|QLGN (Qualigen Therapeutics, Inc.) - P/E Multiple|AlloVir Bio (ALVR) - Business Payback Period|Price to Earnings Ratio VBI Vaccines Inc. (VBIV)|VIRI - Market Cap to Earnings|Vaxart - Price to Earnings Ratio